Global Methotrexate 麻豆原创 Research Report 2023

Publication ID:

PB501239851

Publication Date:

January 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Highlights
The global Methotrexate market was valued at US$ 517.2 million in 2022 and is anticipated to reach US$ 624.6 million by 2029, witnessing a CAGR of 2.7% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methotrexate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate.
The Methotrexate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Methotrexate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Methotrexate 麻豆原创 Overview
1.1 Product Overview and Scope of Methotrexate
1.2 Methotrexate Segment by Type
1.2.1 Global Methotrexate 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Methotrexate for Injection
1.2.3 Methotrexate Tablets
1.3 Methotrexate Segment by Application
1.3.1 Global Methotrexate 麻豆原创 Value by Application: (2023-2029)
1.3.2 Used for Cancers
1.3.3 Used for Rheumatoid Arthritis
1.3.4 Used for Other Diseases
1.4 Global Methotrexate 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Methotrexate Revenue 2018-2029
1.4.2 Global Methotrexate Sales 2018-2029
1.4.3 Global Methotrexate 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Methotrexate 麻豆原创 Competition by Manufacturers
2.1 Global Methotrexate Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Methotrexate Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Methotrexate Average Price by Manufacturers (2018-2023)
2.4 Global Methotrexate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methotrexate, Product Type & Application
2.7 Methotrexate 麻豆原创 Competitive Situation and Trends
2.7.1 Methotrexate 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Methotrexate Players 麻豆原创 Share by Revenue
2.7.3 Global Methotrexate 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Methotrexate Retrospective 麻豆原创 Scenario by Region
3.1 Global Methotrexate 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Methotrexate Global Methotrexate Sales by Region: 2018-2029
3.2.1 Global Methotrexate Sales by Region: 2018-2023
3.2.2 Global Methotrexate Sales by Region: 2024-2029
3.3 Global Methotrexate Global Methotrexate Revenue by Region: 2018-2029
3.3.1 Global Methotrexate Revenue by Region: 2018-2023
3.3.2 Global Methotrexate Revenue by Region: 2024-2029
3.4 North America Methotrexate 麻豆原创 Facts & Figures by Country
3.4.1 North America Methotrexate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Methotrexate Sales by Country (2018-2029)
3.4.3 North America Methotrexate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Methotrexate 麻豆原创 Facts & Figures by Country
3.5.1 Europe Methotrexate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Methotrexate Sales by Country (2018-2029)
3.5.3 Europe Methotrexate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methotrexate 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Methotrexate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Methotrexate Sales by Country (2018-2029)
3.6.3 Asia Pacific Methotrexate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Methotrexate 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Methotrexate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Methotrexate Sales by Country (2018-2029)
3.7.3 Latin America Methotrexate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Methotrexate 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Methotrexate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Methotrexate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Methotrexate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Methotrexate Sales by Type (2018-2029)
4.1.1 Global Methotrexate Sales by Type (2018-2023)
4.1.2 Global Methotrexate Sales by Type (2024-2029)
4.1.3 Global Methotrexate Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Methotrexate Revenue by Type (2018-2029)
4.2.1 Global Methotrexate Revenue by Type (2018-2023)
4.2.2 Global Methotrexate Revenue by Type (2024-2029)
4.2.3 Global Methotrexate Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Methotrexate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Methotrexate Sales by Application (2018-2029)
5.1.1 Global Methotrexate Sales by Application (2018-2023)
5.1.2 Global Methotrexate Sales by Application (2024-2029)
5.1.3 Global Methotrexate Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Methotrexate Revenue by Application (2018-2029)
5.2.1 Global Methotrexate Revenue by Application (2018-2023)
5.2.2 Global Methotrexate Revenue by Application (2024-2029)
5.2.3 Global Methotrexate Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Methotrexate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Corporation Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Qualitestrx (DAVA Pharmaceuticals)
6.2.1 Qualitestrx (DAVA Pharmaceuticals) Corporation Information
6.2.2 Qualitestrx (DAVA Pharmaceuticals) Description and Business Overview
6.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
6.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments/Updates
6.3 Pfizer (Hospira)
6.3.1 Pfizer (Hospira) Corporation Information
6.3.2 Pfizer (Hospira) Description and Business Overview
6.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
6.3.5 Pfizer (Hospira) Recent Developments/Updates
6.4 Roxane Laboratories
6.4.1 Roxane Laboratories Corporation Information
6.4.2 Roxane Laboratories Description and Business Overview
6.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roxane Laboratories Methotrexate Product Portfolio
6.4.5 Roxane Laboratories Recent Developments/Updates
6.5 Sine
6.5.1 Sine Corporation Information
6.5.2 Sine Description and Business Overview
6.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sine Methotrexate Product Portfolio
6.5.5 Sine Recent Developments/Updates
6.6 Maoxiang
6.6.1 Maoxiang Corporation Information
6.6.2 Maoxiang Description and Business Overview
6.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Maoxiang Methotrexate Product Portfolio
6.6.5 Maoxiang Recent Developments/Updates
6.7 LingNan Pharmaceutical
6.6.1 LingNan Pharmaceutical Corporation Information
6.6.2 LingNan Pharmaceutical Description and Business Overview
6.6.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LingNan Pharmaceutical Methotrexate Product Portfolio
6.7.5 LingNan Pharmaceutical Recent Developments/Updates
6.8 Powerdone
6.8.1 Powerdone Corporation Information
6.8.2 Powerdone Description and Business Overview
6.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Powerdone Methotrexate Product Portfolio
6.8.5 Powerdone Recent Developments/Updates
6.9 Huiyu
6.9.1 Huiyu Corporation Information
6.9.2 Huiyu Description and Business Overview
6.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huiyu Methotrexate Product Portfolio
6.9.5 Huiyu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methotrexate Industry Chain Analysis
7.2 Methotrexate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methotrexate Production Mode & Process
7.4 Methotrexate Sales and 麻豆原创ing
7.4.1 Methotrexate Sales Channels
7.4.2 Methotrexate Distributors
7.5 Methotrexate Customers
8 Methotrexate 麻豆原创 Dynamics
8.1 Methotrexate Industry Trends
8.2 Methotrexate 麻豆原创 Drivers
8.3 Methotrexate 麻豆原创 Challenges
8.4 Methotrexate 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.